Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44 ARTÍCULOS , VIENDO DEL 1 AL 15

Clinical characteristics associated with GAD65 antibodies: a comparative study between high and low GAD65-ab cohorts

Lombardo-Del Toro P, Jaraba S, Hernández-Pérez G, Nedkova V, Casasnovas C, Jauma-Classen S, Gonzalez-Mera L, Gómez-Llopico R, García-Serrano L, Sala-Padró J, Morandeira F, Falip M.

Front Neurol. 2026 Oct 19;17:1976777. doi: 10.3389/fneur.2026.1976777. eCollection 2026.

Chimeric antigen receptor T cell therapy in autoimmune neurological disease: current status of efficacy and safety

Bradhurst P, Hardy TA, Riminton S.

BMJ Neurol Open. 2026 Sep 29;8(2):e001611. doi: 10.1136/bmjno-2026-001611. eCollection 2026.

CAR-T-cell therapy for autoimmune neurologic diseases

Zhao Y, Ding Y, Tang C, Wei Z, Fan Y, Hu X, Yi J.

Front Immunol. 2026 Oct 12;17:1942249. doi: 10.3389/fimmu.2026.1942249. eCollection 2026.

The Roles and Uses of Extracellular Vesicles in Neuroimmunologic Diseases

Kammeyer R, Coughlan C.

J Neurosci. 2026 Oct 21;46(42):e2310252026. doi: 10.1523/JNEUROSCI.2310-25.2026.

Unmasking the Connection: Cardiac Arrest in Stiff Person Syndrome

Sujanyal S, Alaws H, Helgeson SA.

Ther Adv Pulm Crit Care Med. 2026 Sep 10;21:29768675261485672. doi: 10.1177/29768675261485672. eCollection 2026 Jan-Dec.

Stiff Person Syndrome in the Hospice Patient: A Case Report and Discussion

Svendsen M, Layton BP, Etzioni S, Edwin M.

J Palliat Med. 2026 Aug;29(8):1175-1177. doi: 10.1177/10966218251387432. Epub 2025 Oct 13.

[Stiff-person syndrome; the diagnostic challenges of a treatable condition]

Bos JW, de Vries JM, van Doormaal PTC.

Ned Tijdschr Geneeskd. 2026 Jun 2;170:D8853.

Triple islet autoantibody-positive type 1 diabetes in Japanese stiff-person syndrome despite a protective HLA haplotype

Suenaga M, Ogiso K, Takeuchi N, Akahoshi H, Nishio Y, Morino K.

JCEM Case Rep. 2026 Jun 9;4(7):luag154. doi: 10.1210/jcemcr/luag154. eCollection 2026 Jul.

Clinical heterogeneity and immunotherapy outcomes in anti-GAD65 antibody-associated autoimmune encephalitis: a retrospective study

Qiu Y, Huang Z, Ma T, Lan L, Ma G, Nie K, Zhang Y, Wang L, Zhao J.

Ther Adv Neurol Disord. 2026 Jun 9;19:17562864261456519. doi: 10.1177/17562864261456519. eCollection 2026.

Movement disorders with autoimmune neuromuscular origin: an overview of Isaacs' syndrome, stiff person syndrome, immune-mediated rippling muscle disease

Arimura K, Rosales RL, Arimura Y, Yu GLT.

J Neural Transm (Vienna). 2026 Jun 29. doi: 10.1007/s00702-026-03220-1. Online ahead of print.

Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis

Hu Y, Wen M, Wen L, Cheng R, Shen Y, Aboseif A, Shang P.

J Neurol. 2026 Jul 2;273(8):442. doi: 10.1007/s00415-026-13981-0.

Sequential efgartigimod and ofatumumab for stiff-person syndrome: a case report illustrating a pathophysiology-informed strategy and literature review

Yang C, Zhou J, Jiang H.

Front Immunol. 2026 Jun 26;17:1811565. doi: 10.3389/fimmu.2026.1811565. eCollection 2026.

Case Report: Efgartigimod: a beacon of hope for overlapping stiff-person syndrome and myasthenia gravis following thymoma

Nie J, Yin W.

Front Immunol. 2026 Jul 20;17:1825974. doi: 10.3389/fimmu.2026.1825974. eCollection 2026.

Anti-Amphiphysin Stiff-Person Spectrum Disorders: A Systematic Review and Case Series Featuring an Unusual Isolated Upper-Limb Presentation

Lee AL, Garg D, Schee JP, Dy Closas AMF, Tee JWY, Wong ESY, Goh KJ, See MH, Tai MS, Tan AH, Lim SY.

Mov Disord Clin Pract. 2026 Aug 14:10.1002/mdc3.70770. doi: 10.1002/mdc3.70770. Online ahead of print.

Clinical approach to neurological paraneoplastic syndromes

Anderson NE.

Intern Med J. 2026 Aug;56(8):1314-1322. doi: 10.1111/imj.70500. Epub 2026 Jul 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias